Oxidative stress: a role in the pathogenesis of Parkinson's disease
- PMID: 2193108
- DOI: 10.1007/978-3-7091-9050-0_23
Oxidative stress: a role in the pathogenesis of Parkinson's disease
Abstract
The degeneration of nigro-striatal dopaminergic neurons is considered to be a predominant pathogenetic factor of Parkinson's disease (PD). However, the etiology of this degeneration is not known. Hypotheses assume accumulation of endogenous and/or exogenous toxins as trigger of the disease. An increase in the concentration of free radicals has been suggested to be toxic to cells, especially when combined with certain metals like free iron or copper. The role of melanin in the degenerative process is not clear, but autoxidative reactions such as the oxidation of dopamine (DA) to melanin generating radicals and toxic metabolites seem to enhance the vulnerability of neurons in the substantia nigra (SN). Disappearance of melanin in the SN, increase of total iron and ferric iron, extreme decrease of glutathione (GSH) levels, reduced activity of enzymes involved in the detoxification of hydrogen peroxide, hydroxyl and superoxide radicals (peroxidases, catalase, glutathione peroxidase), an increase of monoamine oxidase B (MAO B) activity and the substantial increase of malondialdehyde, a marker of lipid peroxidation, in the SN seem to indicate a role of an oxidative stress syndrome in the SN causing or aggravating PD.
Similar articles
-
The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson's disease.J Neural Transm Suppl. 1990;32:239-48. doi: 10.1007/978-3-7091-9113-2_34. J Neural Transm Suppl. 1990. PMID: 2089094 Review.
-
Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction.J Neural Transm Suppl. 1990;29:251-8. doi: 10.1007/978-3-7091-9050-0_24. J Neural Transm Suppl. 1990. PMID: 2193109 Review.
-
The role of transition metals in the pathogenesis of Parkinson's disease.J Neurol Sci. 1995 Dec;134 Suppl:69-78. doi: 10.1016/0022-510x(95)00210-s. J Neurol Sci. 1995. PMID: 8847547
-
Oxidative stress and the pathogenesis of Parkinson's disease.Neurology. 1996 Dec;47(6 Suppl 3):S161-70. doi: 10.1212/wnl.47.6_suppl_3.161s. Neurology. 1996. PMID: 8959985 Review.
-
Iron, melanin and dopamine interaction: relevance to Parkinson's disease.Prog Neuropsychopharmacol Biol Psychiatry. 1993 Jan;17(1):139-50. doi: 10.1016/0278-5846(93)90038-t. Prog Neuropsychopharmacol Biol Psychiatry. 1993. PMID: 8416600
Cited by
-
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson's disease.J Neuroinflammation. 2019 Jul 22;16(1):153. doi: 10.1186/s12974-019-1532-2. J Neuroinflammation. 2019. PMID: 31331333 Free PMC article. Review.
-
Superoxide dismutases: a physiopharmacological update.J Physiol Biochem. 2009 Jun;65(2):195-208. doi: 10.1007/BF03179070. J Physiol Biochem. 2009. PMID: 19886398 Review.
-
Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?J Neural Transm Gen Sect. 1993;92(2-3):187-95. doi: 10.1007/BF01244877. J Neural Transm Gen Sect. 1993. PMID: 8369108 Review.
-
A brief history of brain iron accumulation in Parkinson disease and related disorders.J Neural Transm (Vienna). 2022 Jun;129(5-6):505-520. doi: 10.1007/s00702-022-02505-5. Epub 2022 May 9. J Neural Transm (Vienna). 2022. PMID: 35534717 Free PMC article. Review.
-
Oxidative stress induced carbonylation in human plasma.J Proteomics. 2011 Oct 19;74(11):2395-416. doi: 10.1016/j.jprot.2011.07.014. Epub 2011 Jul 30. J Proteomics. 2011. PMID: 21856457 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical